There is a significant expansion of both CD4ϩ and CD8ϩ 
and intracellular storage of IL-16 as determined by immunohistochemical staining (6) . Although IL-16 is not detected The cellular components of allergic airway inflammation in the bronchoalveolar lavage (BAL) fluid of individuals are primarily lymphocytes, eosinophils, and mast cells (1) (2) (3) .
with stable atopic asthma, it is rapidly released following Influx of these cells to the bronchial epithelium and subepiairway challenge with either allergen or histamine (7, 8) . thelium likely occurs due to chemoattractant factors generThese data indicate that sensitization alone primes for the ated by both resident epithelial cells and recruited effector rapid expression of T H 2 cytokines by T cells and IL-16 by cells responsible for perpetuating the immune response. the epithelium. Mast cells and eosinophils, through the release of vasoactive IL-16 is a protein initially characterized as an in vitro amines, tryptases, and leukotrienes, are directly responsible chemoattractant factor for CD4ϩ T cells (9); it is now known for several of the physiologic alterations consequent to allerthat other CD4ϩ cells are also responsive. IL-16 stimulation gic inflammation, such as bronchoconstriction and mucosal of CD4ϩ T cells results in upregulation of IL-2R␣ (CD25), edema. CD4ϩ lymphocytes of the T-helper 2 (T H 2) subtype facilitating a proliferative response to either IL-2 or IL-15 (10). In addition, IL-16 has been reported to regulate the response of T cells to antigenic stimulation (11, 12) as well with asthma, which were absent in those without asthma hyde), respectively, were purchased from Bachem (Torrance, CA). Anti-IL-16 monoclonal antibody was isolated from clone 14.1 (6) 
Materials and Methods
aprotonin, and leupeptin (all obtained from Sigma Chemicals) as Reagents previously described (26, 27) .
In some experiments, caspase-specific peptides were used to Murine tumor necrosis factor ␣ (mTNF-␣) was obtained from R&D Systems (Minneapolis, MN). Serotonin (5-HT) was purdemonstrate caspase-3 enzymatic activity in IL-16 processing (28).
For those experiments, peptides Ac-DEVD-CHO or Ac-YVADattached to substrate peptide sequence. Cell lysates were assayed CHO (100 M each) in PBS were added to the cell cultures 5 for caspase-3 activity per manufacturer's instructions (Medical and min before the addition of TNF-␣, and remained in the cultures Biological Laboratories Co., Ltd, Nagoya, Japan). Briefly, after throughout the experiment. In some experiments, cycloheximide rinsing twice with PBS, cells are harvested and subjected to a (20 g/ml) was added 2 h before cytokine stimulation to prevent detergent-based lysis buffer from the manufacturer. Cell lysates de novo protein synthesis.
are incubated with an equal volume of 2ϫ reaction buffer and DEVD-AFC in the dark at 37ЊC. Fluorescence with 350 nm excitation and 510 nm emission wavelengths were assayed at 2-3 h of incubation. Caspase-3 activity is expressed as fold increase of Chemotaxis diluent-treated control dishes. The presence of bioactive IL-16 in epithelial cell supernatants was determined by the induction of human T lymphocyte migration using a modified Boyden chemotaxis chamber technique, as de- cretion (6, 8, 21) . To determine whether the low concentrations of TNF-␣ observed in the serum and BAL fluid of sensitized mice could induce the synthesis and storage of IL-16, cell lysates were collected in parallel with the superWe next determined whether TNF-␣ was elevated sysnatants described in Figure 2A and were assessed for IL-16 temically and in the BAL fluid of OVA-sensitized mice.
bioactivity following 24 h of TNF-␣ stimulation. In contrast TNF-␣ was detected in the sera of sensitized mice at a to supernatants, cell lysates contained IL-16 bioactivity reconcentration of 23 Ϯ 8 pg/ml. TNF-␣ was not detected by sulting from 1 pg/ml TNF-␣ ( Figure 2B ). The amount of ELISA in either BAL fluid from sensitized mice or in the IL-16 bioactivity and protein, detected in association with serum or BAL fluid from unsensitized mice.
cell lysates, peaked with the 10 pg/ml concentration of TNF-␣ and decreased with higher concentrations. This cor-
Induction of IL-16 Generation by TNF-␣ in LA-4 Cells
relates with an increase in detectable chemoattraction obThere appeared to be a mechanistic difference in the generserved in the supernatants with higher concentrations of ation of IL-16 between high doses of TNF-␣ (100 ng/ml) TNF-␣ stimulation, suggesting that lower concentrations of (24) and lower concentrations found in serum (20 pg/ml) TNF-␣ can stimulate synthesis of IL-16 without detectable in the current study. To further characterize the response release. Higher concentrations induce synthesis and release, of murine BEC to direct stimulation with TNF-␣, LA-4 resulting in less intracellular IL-16. Quantification of both cells were stimulated in a dose-dependent fashion with resecreted and intracellular IL-16 is depicted in Table 1 . The combinant murine TNF-␣ for 24 h. The supernatant was cause of slightly lower levels of T cell chemoattractant activassessed for chemoattractant activity of human T cells. As ity in cell lysates compared with supernatants is unclear, shown in Figure 2A , TNF-␣ alone induced an increase in but is presumably due to the presence of inhibitory proteins chemoattractant activity from LA-4 cells at concentrations of 50 pg/ml or greater. IL-16 represented at least 50% of and/or proteases in whole-cell sonicates. Requirement of Caspase-3 Activity for Generation of 5-HT did result in significant levels of T cell chemoattractant activity in the cell supernatant. Co-incubation of supernaBioactive IL-16 tant with neutralizing anti-IL-16 antibody resulted in a In T cells and fibroblasts, IL-16 processing by caspase-3 is 50-60% loss of chemoattractant activity, indicating that a required for generation of bioactive IL-16 (28, 30) . To assess majority of the activity was attributable to IL-16. To deterwhether the intracellular generation of IL-16 at TNF-␣ mine whether 5-HT was inducing de novo synthesis of prodoses that were insufficient to elicit secretion (depicted in tein or acting solely as a secretagogue for preformed pro- Figure 2B ) was dependent on caspase-3, cells were incutein, LA-4 cells were stimulated with TNF-␣ for 24 h and bated with either Ac-DEVD-CHO (100 M), a specific then incubated with cycloheximide (20 g/ml for 2 h) before caspase-3 inhibitor, or Ac-YVAD-CHO (100 M), a spe-5-HT stimulation. Cycloheximide-treated cells secreted comcific caspase-1 inhibitor, for 24 h before stimulation. Cells parable levels of bioactivity as untreated cells when stimuwere then stimulated for 24 h with TNF-␣ 1 pg/ml in the lated with TNF-␣ followed by 5-HT stimulation, indicating presence or absence of caspase inhibitors, and sonicates that de novo protein synthesis was not induced by 5-HT harvested and subjected to T cell chemotaxis assay. As stimulation. To demonstrate that the cycloheximide was depicted in Figure 3A , the caspase-3 inhibitor peptide Acefficiently blocking protein synthesis, cells were treated with DEVD-CHO abrogated generation of intracellular IL-16. Peptide Ac-DEVD-CHO alone had no effect on the cell migration assay, and higher doses of TNF-a (50 pg/ml) did not override caspase-3 inhibition with respect to secretion of IL-16 (data not shown). To confirm that low-dose TNF-␣ 1 h before BAL with PBS. The BAL fluid was concentrated 10-fold and then subjected to T cell chemotaxis assay. As demonstrated in Figure 6 , the BAL fluid from OVA-sensicycloheximide before stimulation with TNF-␣ (50 pg/ml) tized mice challenged with 5-HT contained T cell chemofor 24 h. Under this condition, no chemoattractant activity attractant bioactivity, the majority of which was attributable was detected in the cell supernatant (data not shown). These to IL-16. of IL-16 bioactivity associated with asthmatic epithelium or in combination with TNF-␣ (50 pg/ml) stimulation (data (21). They determined that primary epithelial cells derived not shown). In the presence of TNF-␣ (1 pg/ml) in comfrom individuals with asthma cultured in the presence of bination with 5-HT stimulation, release of all chemoattrachistamine released IL-16; however, no IL-16 bioactivity was tant activity was completely blocked by methiopthepin, LY53857, and by ketanserin ( Figure 5 ). In the presence of detected before histamine stimulation. Using immunohistopindobind, the T cell migratory response was identical to that induced by serotonin alone. Taken together, this data indicates that stimulation of epithelial cells with lower concentrations of TNF-␣ results in generation of processed intratracheally challenged with 10 Ϫ7 M 5-HT (100 l) for chemical staining and in situ hybridization of lung tissue cells, as neutralizing antibodies had no effect. This observation is consistent with the findings that T H 2 cytokine producobtained from individuals with asthma, these initial observations identifying that airway epithelial cells contained tion in the lung is not detected until after antigenic challenge (5) . This suggests that IL-9 generated in conjunction with high levels of IL-16 message and protein were confirmed (6) . This study also highlighted the concept that elevated secondary challenge is capable of further upregulating IL-16 production. It is conceivable that 5-HT produced levels of IL-16 expression by airway epithelial cells in vivo were asthma-specific, as tissue obtained from normal or by activated mast cells in response to antigenic challenge induces a rapid release of stored IL-16, and that IL-9 stimuatopic individuals without asthma only expressed sporadic pockets of low levels of both IL-16 message and protein lation would function to further upregulate de novo synthesis of IL-16 protein. (6) . This same specificity appears to exist in mice. IL-16 staining in the lungs of control, unsensitized mice had undeThis mechanism for IL-16 synthesis, processing, and release is similar to the mechanism identified in CD8ϩ T tectable IL-16 protein, whereas the epithelium from OVAsensitized mice contained detectable levels of IL-16 (22) .
cells. CD8ϩ T cells express constitutive IL-16 mRNA and pro-IL-16 protein, as well as constitutively active caspase-3. However, whereas IL-16 is readily detected in the BAL fluid of individuals with asthma or that of sensitized mice
The result is the constitutive expression and storage of bioactive IL-16 (26, 27) . Vasoactive amine stimulation reas early as 2-6 h following antigenic challenge, IL-16 is not detected in the BAL fluid from either unchallenged sults in release of processed IL-16 independent of de novo protein synthesis. A human epithelial cell line, BEAS-2B, individuals with asthma (7) or sensitized but unchallenged mice (22) . These findings suggest that cytokines generated has been shown to have constitutive IL-16 message with histamine-inducible secretion of bioactive protein (24). Asduring the sensitization phase induce epithelial cell synthesis, but not secretion, of IL-16. IL-16 is then released from sessment of unstimulated cell lysates identified the presence of stored bioactive IL-16 in this cell line (unpublished obserthe epithelium following airway challenge with allergen or vasoactive amine stimulation.
vations). These observations are consistent with the findings that histamine challenge of individuals with asthma results Cytokines which induce epithelial cell-derived IL-16, and the mechanism by which epithelial cells synthesis and in secretion of IL-16, as detected in the BAL fluid. Unlike the BEAS-2B cell line, which may display an asthmaticsecrete IL-16, are currently not well understood. To better understand the process of IL-16 generation in the lung, we like phenotype, the epithelial cell line used for our studies appears to be similar to primary epithelial cells found in used a murine system to investigate the apparent two-step mechanism for IL-16 production and secretion in vivo. We individuals without asthma. These cells do not contain constitutively expressed IL-16, and are unresponsive to vasochose to determine the effects of TNF-␣ and IL-9 on epithelial cell priming because reports have indicated that these active amine stimulation unless primed with cytokines such as TNF-␣. cytokines can induce synthesis and secretion of IL-16 (23, 24). We detected elevated levels of TNF-␣ in the serum of Confirmation of the involvement of TNF-␣ in the induction of IL-16 in vivo was established using sera and BAL sensitized mice. These levels, however, were far below those reported to induce IL-16 protein production and secretion fluid isolated from OVA-sensitized mice. Stimulation of LA-4 cells by the OVA-sensitized sera or BAL fluid resulted in vitro (24). They were sufficient, however, to induce generation of bioactive IL-16. At this concentration of TNF-␣, in priming of the epithelial cells that were induced to release bioactive IL-16 with subsequent 5-HT stimulation. Inhibi-IL-16 was not secreted into the supernatant, but was detected upon cell lysis or stimulation with 5-HT. The prestion of TNF-␣ did not completely eliminate generation of these cytokines, indicating that other factors contained ence of bioactive IL-16 contained within the cell with no detectable secretion is similar to what is observed in the within the serum or BAL fluid could also prime for IL-16 production and secretion. The ability of TNF-␣ to induce epithelium of an asthmatic or sensitized but unchallenged mouse. IL-16 is then secreted following stimulation with IL-16 priming is consistent with other studies identifying its presence in BAL fluid from individuals with asthma (33, 5-HT. Serotonin, acting though the S2 receptor, appears to function in this system primarily as a secretagogue, as alone 34) and its ability to induce synthesis of epithelial cellderived IL-6 (24), eosinophil chemotactic activity (ECA) it was not sufficient to induce IL-16 production either in vitro in LA-4 cell cultures or in vivo as assessed in BAL fluid (35), and expression of ICAM-1 (36). Despite the similarities between in vivo and in vitro observations, our findings from unsensitized mice. In addition, inhibition of protein synthesis in vitro had no effect on 5-HT-induced IL-16 should be interpreted in light of the fact that LA-4 cells are from a cell line and may not respond identically to release. These findings have two implications. The first is that systemic sensitization alone is sufficient to induce genprimary cells. The primary source(s) of TNF-␣ affecting the airway eration of IL-16 in the airway epithelium, likely through the generation of immune-related cytokines, such as TNF-␣. epithelium has not been identified; B cells, T cells, and macrophages activated during the sensitization phase are The second implication is that the epithelium is capable of synthesizing, processing, and storing bioactive IL-16 in likely candidates. Gajewska and coworkers report that there is a significant increase in B cell numbers in the thoracic response to an initial stimulation, which is then secreted with a secondary stimulus. lymph nodes following sensitization alone (5). It is possible that these B cells, activated in response to the sensitization We have reported previously that the T H 2 cytokine IL-9 stimulation results in epithelial cell generation of IL-16 (23).
phase, generate the increased TNF-␣ levels detected in the sera from these mice, which we demonstrate to be sufficient IL-9 does not appear to be involved with priming epithelial The importance of epithelial cell priming resulting in tein levels in the epithelium are further upregulated follow-
